I am really pleased with this announcement. There’s not a lot more to say than reading between the lines, Tier 1 are big labs/Pharma & Insurance companies wanting this test on board for USA healthcare to save them billions of dollars on dialysis. We knew this was coming PIQ people. Not going to speculate on who, but Janssen (J&J) collaboration & wanting an option to buy out PromarkerD & predictive testing on both DKD & cardiac disease may well have something to do with voiding this deal. IMO & GLTAH
Ann: PromarkerD US market update, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $48.23M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 29.0¢ | $81.32K | 272.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 31471 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 28012 | 2 |
View Market Depth
| Last trade - 13.13pm 27/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |